πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 1,022 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7553867

Furan or thiophene derivative and medicinal use thereof

Takeda Pharmaceutical Company Limited Β· Granted Tue Jun 30 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 25 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7550590

Dipeptidyl peptidase inhibitors

Takeda Pharmaceutical Company Limited Β· Granted Tue Jun 23 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 18 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7550598

Kinase inhibitors

Takeda Pharmaceutical Company Limited Β· Granted Tue Jun 23 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 18 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7541478

Coumarin derivative and use thereof

Takeda Pharmaceutical Company Limited Β· Granted Tue Jun 02 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 28 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7538133

Benzimidazole derivatives, their production and use

Takeda Pharmaceutical Company Limited Β· Granted Tue May 26 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 21 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7538125

Pharmaceutical composition

Takeda Pharmaceutical Company Limited Β· Granted Tue May 26 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 21 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7534887

Thiazoline derivative and use of the same

Takeda Pharmaceutical Company Limited Β· Granted Tue May 19 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 14 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7521545

Azo compounds and process for production thereof

Takeda Pharmaceutical Company Limited Β· Granted Tue Apr 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7517661

Methods of screening for ligands for FPRL2

Takeda Pharmaceutical Company Limited Β· Granted Tue Apr 14 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7517910

Alkoxyphenylpropanoic acid derivatives

Takeda Pharmaceutical Company Limited Β· Granted Tue Apr 14 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7514441

Substituted pyrazolo [1,5-A]pyrimidines as calcium receptor modulating agents

Takeda Pharmaceutical Company Limited Β· Granted Tue Apr 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7510728

Solid preparations

Takeda Pharmaceutical Company Limited Β· Granted Tue Mar 31 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7507740

Fused heterocyclic compound

Takeda Pharmaceutical Company Limited Β· Granted Tue Mar 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7507841

Cannabinoid receptor modulator

Takeda Pharmaceutical Company Limited Β· Granted Tue Mar 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7498337

Acid secretion inhibitor

Takeda Pharmaceutical Company Limited Β· Granted Tue Mar 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7498352

TGF-Ξ² superfamily production/secretion promoter

Takeda Pharmaceutical Company Limited Β· Granted Tue Mar 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7495018

Substituted 1,3-thiazole compounds, their production and use

Takeda Pharmaceutical Company Limited Β· Granted Tue Feb 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7491802

Anti-BAMBI antibody and diagnostic or remedy for colon cancer and liver cancer

Takeda Pharmaceutical Company Limited Β· Granted Tue Feb 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7479484

Peptides and peptidomimetics having immune-modulating, anti-inflammatory, and anti-viral a

Takeda Pharmaceutical Company Limited Β· Granted Tue Jan 20 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7476657

Peptides and peptidomimetics having anti-proliferative activity and/or that augment nuclei

Takeda Pharmaceutical Company Limited Β· Granted Tue Jan 13 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7470700

Dipeptidyl peptidase inhibitors

Takeda Pharmaceutical Company Limited Β· Granted Tue Dec 30 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7465815

Cannabinoid receptor modulator

Takeda Pharmaceutical Company Limited Β· Granted Tue Dec 16 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 11 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7462628

Preventives/remedies for urinary disturbance

Takeda Pharmaceutical Company Limited Β· Granted Tue Dec 09 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7462635

Thiazole and oxazole VDAC regulator

Takeda Pharmaceutical Company Limited Β· Granted Tue Dec 09 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted